TITLE

Obesity: Health costs estimated at $75 billion

PUB. DATE
August 2006
SOURCE
Drug Store News;8/28/2006, Vol. 28 Issue 10, p50
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article provides an overview of the anti-obesity drug market in the United States. Data showed that 32 percent of American adults are obese, which represents more than 60 percent increase in the prevalence of obesity since 1993. Overweight and obesity are associated with an increased risk of developing hypertension, type 2 diabetes and heart disease. Roche's Xenical and Abbott's Meridia are the leading anti-obesity drugs in the market.
ACCESSION #
22273254

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics